Press release
The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Bispecific Antibody Therapeutics Market (4th Edition), 2020-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics over the next decade. The study features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. Amongst other elements, the report includes:
A detailed assessment of the current market landscape of drug developers engaged in the development of bispecific antibody therapeutics.
A comprehensive analysis of novel technology platforms that are either currently available or being developed for the generation of bispecific antibody therapeutics.
Detailed profiles of marketed and clinical stage (phase II and phase III) bispecific antibody therapeutics.
Key takeaways from the bispecific antibody therapeutics pipeline.
An analysis of the initiatives of big biopharma players engaged in this domain.
An analysis of recent partnerships and collaboration agreements inked in bispecific antibody therapeutics domain.
A review on the key steps involved and challenges associated with the manufacturing of bispecific antibodies.
A clinical trial analysis of ongoing and planned studies related to bispecific antibody therapeutics.
A review of the key promotional strategies that have been adopted by the developers of the marketed bispecific antibodies.
A discussion on important, industry-specific trends, key market drivers and challenges, under a SWOT framework.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Target Disease Indication
Autoimmune Disorders
Eye Disorders
Genetic Disorders
Hematological Malignancies
Infectious Diseases
Inflammatory Disorders
Skin Disorders
Mechanism of Action
Cytokines Retargeting / Neutralization
Dual Ligands Blocking
T-cell Retargeting / Activation
Others
Target Antigens
CD3 x CD19
CD30 x CD16A
Factor IXa x Factor X
IL-1α x IL-1β
IL-13 x IL-4
IL-17A x Albumin
IL-17A x IL-17F
Psl x PcrV
TNF-α x HAS
VEGF-A x ANG2
Others
Antibody Format
Asymmetric
Fragments
Symmetric
Others
Key Geographical Region
North America
Europe
Asia-Pacific
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
Transcripts of interviews held with the following senior level representatives of stakeholder companies:
Martin Steiner (Chief Executive Officer, Synimmune)
Ludger Große-Hovest (Chief Scientific Officer, Synimmune)
Jane Dancer (Chief Business Officer, F-Star)
Siobhan Pomeroy (Senior Director, Business Development, Cytom X)
Yinjue Wang (Associate Director, Process Development, Innovent Biologics)
Key companies covered in the report
Amgen
Ablynx
AbbVie
Affibody
Affimed
Alphamab
AstraZeneca
Avillion
Chugai Pharmaceuticals
Eddingpharm
GSK
Merck
Merus
Roche
Regeneron Pharmaceuticals
Taisho Pharmaceuticals
Zymeworks
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/bispecific-antibodies/286.html
Other Recent Offerings
1. Global Preventive Vaccines Market, 2020-2030
2. Endocannabinoid System Targeted Therapeutics Market, 2019-2030
3. Antibody Contract Manufacturing Market, 2020-2030
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030, predicts Roots Analysis here
News-ID: 2194951 • Views: …
More Releases from Roots Analysis
Microbial Fermentation CMO Market Set to Triple by 2035, Fueled by Biologics Boo …
The microbial fermentation contract manufacturing organization (CMO) market is on an exciting growth trajectory, projected to soar from USD 3.6 billion in 2024 to over USD 9.1 billion by 2035. This robust expansion, at a compound annual growth rate (CAGR) of 8.7%, reflects the rising demand for biologics and the increasing trend of outsourcing microbial fermentation processes to specialized CMOs, according to a comprehensive new report by Roots Analysis.
Why Microbial…
Peptide Synthesis Market Set to Double by 2035, Driven by Surge in Outsourcing a …
In a world where precision medicine is rapidly reshaping healthcare, the global peptide synthesis market is emerging as a quiet powerhouse. According to a comprehensive new report from Roots Analysis, the sector is poised to leap from a $2.8 billion valuation in 2024 to an impressive $5.1 billion by 2035, growing at a steady 5.5% compound annual growth rate (CAGR). This growth is fueled by a perfect storm of scientific…
Global Needles Market Set to Surpass $14.7 Billion by 2035, Fueled by Chronic Di …
In a world where chronic diseases like diabetes, cancer, and heart conditions are on the rise, the humble needle has become an unsung hero of modern medicine. According to a new report from Roots Analysis, the global needles market is poised for remarkable growth-projected to leap from $8.1 billion in 2025 to over $14.7 billion by 2035, growing at a steady 6.1% annual clip. This surge isn't just about numbers;…
ADC Contract Manufacturing Market Set to Soar, Reaching USD 6.8 Billion by 2035
In the fast-evolving world of biopharmaceuticals, the demand for precision and innovation has never been higher. Nowhere is this more evident than in the rapidly expanding market for Antibody-Drug Conjugate (ADC) contract manufacturing. According to a comprehensive new report from Roots Analysis, the global ADC contract manufacturing market is poised for remarkable growth-projected to surge from USD 1.79 billion in 2024 to over USD 6.8 billion by 2035, at a…
More Releases for Disorders
Biological Derived Devices Market Insights and forecast, 2018 to 2026(Regenerati …
Introduction
Biological derived devices are the re-design of the natural and existing biological part, systems and devices for useful purposes. Technological advancements has led to increasing demand for biopharmaceuticals, therapeutic repairs such as stem cell treatments, bone growth stimulators, replacement of cartilage and tissue culture techniques which are unfolding the new aspects for the disease treatment and creating endeavors for regeneration of healthy cells with the replacement of diseased and …
Neuroprosthetics Market 2019 Industry Segmentation by physiological disorders ar …
Neuroprosthetics Market 2019 Scenario
Neuroprosthetics Market was estimated to be USD 5.28 billion in 2016 and expected to reach USD 10.48 billion by 2023. The key factors responsible for driving this are increasing in geriatric population, auditory processing disorders in kids, and increase in spinal cord treatment due to advancement in neuroprosthetics devices.
The factors responsible for the positive growth of this market are increasing prevalence of neural diseases, over active bladder…
Global Vocal Biomarker Market to Experience Significant Growth during the Foreca …
Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known as Vocal Biomarker Market by combining the concept of biological markers with the aforementioned methodology to analyze personality traits.
Claim Sample Report For FREE: https://www.factmr.com/connectus/sample?flag=S&rep_id=719
These vocal biomarkers are…
Behavioral Therapy Market Report 2018: Segmentation by Type (Anxiety Disorders, …
Global Behavioral Therapy market research report provides company profile for American Addiction Centers, ChanceLight, Haven Behavioral Healthcare, Behavioral Health Group, Center for Autism & Related Disorders, People’s Care, Magellan Health, Universal Health Services, Acadia Healthcare, Springstone and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY…
Global Behavioral Rehabilitation Market By Application - Anxiety Disorders, Mood …
Researchmoz added Most up-to-date research on "Global Behavioral Rehabilitation Market By Application - Anxiety Disorders, Mood Disorders, Substance Abuse Disorders & Personality Disorders" to its huge collection of research reports.
This report studies Behavioral Rehabilitation in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
Increasing Incidence of Thyroid Gland Disorders Expected to Propel the Thyroid G …
The number of patients suffering from thyroid gland disorders across the globe is increasing at a rapid rate. This direct increase in demand is expected to be a primary driver for the development of thyroid gland disorder treatments. The number of patients with thyroid gland disorder is increasing due to a growing population of the elderly, who are prone to thyroid disorders and similar illnesses.
Additionally, a person suffering from…
